$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
氘可来昔替尼(Deucravacitinib)在中国上市了吗?好购买吗?
2025-10-19 11:44:20
Check Details
氘可来昔替尼(Deucravacitinib)的正确购买途径
2025-10-19 11:44:20
Check Details
氘可来昔替尼(Deucravacitinib)导致的不良反应怎么治疗?
2025-10-19 11:44:20
Check Details
氘可来昔替尼(Deucravacitinib)全网公布的2024年的最新价格
2025-10-19 11:44:20
Check Details
氘可来昔替尼(Deucravacitinib)不同版本一盒的最新价格公布
2025-10-19 11:44:20
Check Details
氘可来昔替尼(Deucravacitinib)在哪里买比较靠谱?
2025-10-19 11:44:20
Check Details
阿普斯特价格一览
2025-10-19 11:44:20
Check Details
阿普斯特(MPRILA)在中国上市了吗?好购买吗?
2025-10-19 11:44:20
Check Details
阿普斯特(MPRILA)导致的不良反应怎么治疗?
2025-10-19 11:44:20
Check Details
阿普斯特(Apores)正品有合适的购买方式吗?
2025-10-19 11:44:20
Check Details
阿普斯特(Apremilast)全新购买方式一览
2025-10-19 11:44:20
Check Details
阿普斯特(Apremilast)全网公布的2025年的最新价格
2025-10-19 11:44:20
Check Details
1
2
...
5526
5527
5528
5529
5530
5531
5532
...
10217
10218
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Comprehensive Clinical Guide to Risankizumab (Skyrizi): Dosing, Contraindications, and Safety
2
Management Strategies and Long-Term Outcomes Following 6 Months of Pegloticase (Krystexxa) Therapy
3
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
4
Omaveloxolone (Skyclarys): Side Effect Management and Clinical Guide for Friedreich’s Ataxia
5
Linezolid for MRSA Pneumonia: Efficacy Evidence, Clinical Advantages, and Rational Use
6
Navigating Drug Interactions with Daprodustat: Risks, Adjustments, and Safety Protocols
7
Durvalumab Safety Profile: Managing Immune-Related Adverse Events (irAEs) in Clinical Practice
8
Zolbetuximab Combination Therapy: Global Efficacy and Safety Profile in CLDN18.2-Positive Advanced Gastric Cancer
9
Managing Mitotane Resistance in Adrenocortical Carcinoma: Strategies and Global Options
10
Trametinib & Dabrafenib in 2026: A Global Guide to Treating BRAF-Mutant Cancers
11
A Guide to Safely Stopping Mitotane: Why Tapering is Essential and How to Manage
12
Pemigatinib Efficacy: Significantly Improving Survival in FGFR2-Fusion Cholangiocarcinoma